About Us
Author Guidelines
Contact Us
Supplier Info
 


Current Issue
Sample issue of JATCurrent Issue


Contact Info:
6600 W. Touhy Ave.
Niles, IL 60714
Tel: 847.647.2900
Fax: 847.647.1155
circulation@jatox.com

 

 
   

Journal of Analytical Toxicology Article Abstracts

Journal of Analytical Toxicology Horizontal Line

Published: Journal of Analytical Toxicology, ISSN 0146-4760, Volume 25, Number 7, October, pp. 625-627

TECHNICAL NOTE: The Detection of Drugs of Abuse in Liquid Perspiration
Dennis J. Crouch[1], Royer F. Cook[2], James V. Trudeau[2], David C. Dove[2], Jerome J. Robinson[3], H. Lewis Webster[4], and Alim A. Fatah[5]
[1]The Center for Human Toxicology, University of Utah, 20 South 2030 East Room 490, Salt Lake City, Utah 84112;
[2]The Institute for Social Analysis, Alexandria, Virginia;
[3]Washington Pretrial Services Agency, Washington, D.C.;
[4]Wescor, Inc, Logan, Utah; and
[5]National Institute of Standards and Technology, Gaithersburg, Maryland

Drug testing is widely used in emergency toxicology, the criminal justice system, and in the workplace. Major uses in the criminal justice system include pretrial drug testing (1), drug courts, the Arrestee Drug Abuse Monitoring system, post-adjudication testing by probation and parole departments (2), and testing of law enforcement personnel (3). In the workplace, testing is performed prior to employment, in safety-sensitive positions, randomly, and following accidents that result in personal injury or property damage (4). Urine has been the specimen of choice for emergency toxicology, criminal justice, and workplace testing. However, both the National Institute of Justice (NIJ) (5) and the Substance Abuse and Mental Health Services Administration (SAMHSA) (6) continue to explore new specimens to test for drugs-of-abuse and innovative methods for testing.

Liquid perspiration (sweat) collection devices have been approved for clinical applications and for drugs-of abuse testing (Macroduct® and PharmChek™) (7,8). Several studies have demonstrated the efficacy of detecting drug use through sweat patch testing (9,10). A major limitation of sweat patch testing is that the production of liquid perspiration varies with ambient temperature and physical activity. Therefore, the volume of perspiration collected by the patch during the week that it is worn is unknown. This precludes meaningful (drug per milliliter of perspiration) quantitative analysis of drugs detected on the patch and limits the interpretative value of a sweat patch drug test result. Therefore, we evaluated the feasibility of collecting and testing liquid perspiration for drugs of abuse.

Reproduction of editorial content of this journal is prohibited without publisher’s permission.

This article is available in its entirety by fax for $40.00 each.
Visa, MasterCard and AMEX accepted.

To order electronically click here
or call: 847-647-2900 ext. 1323
or fax request to: 847-647-1155.

To order multiple copies click here.

Please indicate JAT volume and issue along with page numbers.


| Home | Subscribe | Current Issue | Back Issues | Search | Advertise | Other Publications |